微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.07% | 9.25% | 7575% | 25/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.04% | -96% | 103.77% | 36/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -1.06% | -783.33% | 93.69% | 40/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -16.79% | -31.27% | -697.51% | 47/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 2.81% | 277.85% | 181% | 34/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 1% | 126.53% | 933.33% | 34/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -0.12% | 95.99% | 99.06% | 38/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -12.79% | -33.23% | -709.49% | 43/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | -1.58% | -1228.57% | 58.09% | 43/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | -3.77% | -496.84% | -26.09% | 45/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | -2.99% | -708.11% | 68.85% | 40/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -9.6% | 67.35% | -6957.14% | 43/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 0.14% | 106.42% | -85.26% | 32/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 0.95% | 135.58% | 356.76% | 35/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | -0.37% | -270% | 98.74% | 28/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -29.4% | -11860% | -1248.62% | 48/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -2.18% | -91.23% | 18.35% | 28/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -2.67% | -126.27% | -2570% | 32/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -0.1% | 86.67% | -140% | 20/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 0.25% | 105.09% | 121.93% | 40/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | -1.14% | -172.61% | 3.39% | 27/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | -1.18% | -11700% | -57.33% | 29/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | -0.75% | -11.94% | 84.73% | 27/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -4.91% | -202.72% | -412.74% | 40/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 1.57% | -40.53% | 15800% | 23/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | -0.01% | -100.76% | 98.51% | 29/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | -0.67% | -231.37% | -114.02% | 24/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 4.78% | 319.3% | 81.06% | 27/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 2.64% | 13100% | 101.53% | 24/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 1.31% | 227.5% | 156.86% | 25/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 0.51% | 75.86% | -55.26% | 19/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 1.14% | -85.02% | 5600% | 27/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 0.02% | -99.6% | -95% | 18/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 0.4% | -87.5% | 37.93% | 19/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 0.29% | -72.64% | -96.19% | 15/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 7.61% | 94.13% | 51.29% | 22/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 5.03% | 128.64% | 57.19% | 12/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 3.2% | 162.3% | 201.89% | 11/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 1.06% | 202.86% | -72.96% | 11/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |